@article{18b19f2c6f9a41cbb1f67037174475cc,
title = "Evaluation and management of patients with chronic thromboembolic pulmonary hypertension - consensus statement from the ISHLT",
abstract = "ISHLT members have recognized the importance of a consensus statement on the evaluation and management of patients with chronic thromboembolic pulmonary hypertension. The creation of this document required multiple steps, including the engagement of the ISHLT councils, approval by the Standards and Guidelines Committee, identification and selection of experts in the field, and the development of 6 working groups. Each working group provided a separate section based on an extensive literature search. These sections were then coalesced into a single document that was circulated to all members of the working groups. Key points were summarized at the end of each section. Due to the limited number of comparative trials in this field, the document was written as a literature review with expert opinion rather than based on level of evidence.",
keywords = "CTEPH, balloon pulmonary angioplasty, guidelines, pulmonary emboli, pulmonary hypertension, pulmonary thromboendarterectomy",
author = "{de Perrot}, Marc and Deepa Gopalan and David Jenkins and Lang, {Irene M.} and Elie Fadel and Marion Delcroix and Raymond Benza and Heresi, {Gustavo A.} and Manreet Kanwar and Granton, {John T.} and Micheal McInnis and Klok, {Frederikus A.} and Kerr, {Kim M.} and Joanna Pepke-Zaba and Mark Toshner and Anastasia Bykova and Armini, {Andrea M.D{\textquoteright}} and Robbins, {Ivan M.} and Michael Madani and David McGiffin and Wiedenroth, {Christoph B.} and Sebastian Mafeld and Isabelle Opitz and Olaf Mercier and Uber, {Patricia A.} and Frantz, {Robert P.} and Auger, {William R.}",
note = "Funding Information: William R Auger received personal fees from Bayer, Actelion, Cereno Scientific and non-financial support from Bayer outside the submitted work. Raymond Benza received personal fees and institution grants from Bayer and Janssen outside the submitted work. Andrea M D'Armini received personal fees from MSD outside the submitted work. Marion Delcroix reports grants from Actelion and other support from Actelion, Bayer, MSD, Acceleron outside the submitted work. Marc de Perrot received personal fees from Actelion, AstraZeneca, Bayer, Merck, Roche and unrestricted financial support provided to his institution from Bayer outside the submitted work,. Robert P Frantz received personal fees from Janssen, Liquidia, Shouti, and Up-To-Date, institutional grant from Bayer, and institutional payment from United Therapeutics and Gossamer Bio. John T Granton received unrestricted financial support provided to his institution from Bayer and Janssen Pharmaceuticals outside the submitted work. Gustavo A Heresi received personal fees from Bayer, and Janssen outside the submitted work. David Jenkins received personal fees from Actelion and grant from Bayer outside the submitted work. Manreet Kanwar received personal fess from Amiomed, Bayer and CareDx (Advisory Board) outside of the submitted work. Kim M Kerr receives personal fees from Actelion and grants from Bayer outside the submitted work. Erik A Klok received research grants from Bayer, Bristol-Myers Squibb, Boehringer-Ingelheim, MSD, Daiichi-Sankyo, Actelion, the Dutch thrombosis association, The Netherlands Organisation for Health Research and Development and the Dutch Heart foundation, all outside the submitted work. Irene M Lang received personal fees from Janssen, AOP Orphan Pharma, United Therapeutics, and grants from Janssen, AOP Orphan Pharma, Neutrolis, and non-financial support from AOP Orphan Pharma, outside of the submitted work. Michael M Madani received personal fees as a consultant for Wexler Surgical outside the submitted work. Micheal McInnis received personal fees from Bayer outside of the submitted work. Olaf Mercier received personal fees from MSD outside the submitted work. Isabelle Opitz received personal fees from AstraZeneca, MSD, Roche, and AstraZeneca, and grants from Roche, and Medtronic, outside the submitted work. Joanna Pepke-Zaba received personal fess from Actelion, Merck and Bayer. Ivan M Robbins received personal fees from Bayer and Acceleron. His institution received payment for participating in multicenter registry studies and studies evaluating treatment of patients with pulmonary arterial hypertension. Mark Toshner received personal fees from Bayer, MSD, GSK as well as grants and personal fees from Actelion/J&J outside the submitted work. Christoph B Wiedenroth received personal fees Actelion, Bayer, Pfizer, MSD, AOP Orphan Pharmaceuticals, BTG outside the submitted work. Publisher Copyright: {\textcopyright} 2021 International Society for Heart and Lung Transplantation",
year = "2021",
month = nov,
doi = "10.1016/j.healun.2021.07.020",
language = "English (US)",
volume = "40",
pages = "1301--1326",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "11",
}